Single User PDF
GBP 1699.00  

PDF Departmental License
GBP 2999.00  

PDF Site License
GBP 4999.00  

PDF Global Site License
GBP 6999.00  

UK Head Office
+44(0)1494 771734
or Buy Now! online

Hot Reports:
Brazil Healthcare - New Opportunities for Growth


US Non-Invasive Prenatal Diagnostics - Market Insight


Global Genetic Testing Market Forecast to 2015


US Clinical Laboratory Testing Market Assessment


US Cardiac Device Market Analysis


Pharma Leader Series: Top 20 Antibacterial Drug Manufacturers 2012-2022


In Vitro Diagnostics: World Market Outlook 2012-2022


Pharma Wholesale and Distribution Market: World Outlook 2012-2022

Table of Contents

Market Study
Published: January 2012
Pages: 124
Tables: For full details, please email deborahf@cmsinfo.com
From: GBP 1699.00  Buy Now!
Research from: pharmaceuticalmarketresearch
Sector: Biotechnology

What does the future hold for cell-based assays in pharma? Visiongain's report shows you potential revenues and other trends, with data, forecasts and discussions.

Our study analyses products and services for cell-based testing. It covers activities of product developers and pre-clinical contract research organisations.

You discover sales predictions to 2022 at world market, main submarket and national levels. Find potential revenues for products and services.

Also, you receive discussions of many companies in the cell assay industry, seeing their activities and outlooks.

Companies featured include the following:
• BD Biosciences
• Life Technologies
• PerkinElmer
• Beckman Coulter
• Evotec
• GE Healthcare
• Thermo Fisher Scientific
• Covance
• PPD
• Charles River Laboratories
• MD Biosciences.

Looking ahead to 2022, many commercial opportunities exist for cell-based testing. Our report gives you business research and analysis there.

Where are cellular assays heading? Greater need for cellular information earlier in pre-clinical product development stimulates demand for the tests. Our report shows you how their use is increasing in drug discovery and development.

Which developmental processes will benefit most from cell assays? This decade, drug screening and toxicity testing will be important applications for cell-based products and services, our analysis shows.

At present, half of all assays used in pharmaceutical development are cell-based. Miniaturisation and automation are important. We find wide scope for developing the systems and applications from 2012 to 2022, seeing many opportunities.

What are the limitations of cell-based assays? For their potential to be achieved, challenges must be tackled. Systems such as 3D assays will allow for more-accurate simulation of in vivo conditions in cell cultures. Our report explains.

Visiongain's study provides data, analysis and opinion aiming to benefit your research, calculations and presentations. You find answers now in our work.

Revenue forecasts, market shares, developmental trends and discussions

In our report you find revenue forecasting, growth rates and market shares. Also, you have qualitative analyses (SWOT and STEP) and discussion of technologies, existing and in development. You receive 74 tables and charts and two research interviews.

Advantages of Cell-Based Assays: World Market Prospects 2012-2022 for your work

In particular, this study gives you the following knowledge:
• Find potential revenues to 2022 for the world market and submarkets
• See market forecasting to 2022 for US, Japan, EU5, China and India
• Assess leading companies, discovering activities and outlooks
• Review technological developments, assessing trends and prospects
• Investigate competition and opportunities influencing revenues
• Find out what will stimulate and restrain the industry and market
• Analyse pharma R&D spending by stage and find an overall forecast to 2022
• View opinions from our survey, receiving detailed interviews.

There, you find a distinctive mix of quantitative and qualitative analyses with independent predictions. Without our report, you could miss out on information that your competitors are using.

We analyse developments and prospects in cellular testing, helping you to stay ahead.

Companies Listed

Top of Page